These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12069445)

  • 1. Chromogranin A in heart failure.
    Wollert KC; Drexler H
    Eur Heart J; 2002 Jun; 23(12):926-7. PubMed ID: 12069445
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.
    Ceconi C; Ferrari R; Bachetti T; Opasich C; Volterrani M; Colombo B; Parrinello G; Corti A
    Eur Heart J; 2002 Jun; 23(12):967-74. PubMed ID: 12069452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromogranin A, chromogranin B, chromogranin C].
    Takekoshi K
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():407-10. PubMed ID: 16149541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chromogranin A, chromogranin B, chromogranin C].
    Takekoshi K; Nakai T; Matsui Y
    Nihon Rinsho; 1999 Dec; 57 Suppl():234-7. PubMed ID: 10778109
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure.
    Corti A; Ferrari R; Ceconi C
    Adv Exp Med Biol; 2000; 482():351-9. PubMed ID: 11192595
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
    Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Chromogranin A concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancer.
    Yashi M; Tokue A
    J Urol; 2003 Jun; 169(6):2305; author reply 2305. PubMed ID: 12771784
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer biomarkers in heart failure.
    Gupta S; Drazner MH; de Lemos JA
    Heart Fail Clin; 2009 Oct; 5(4):579-88. PubMed ID: 19631181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chromogranin A].
    Sato J
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():547-9. PubMed ID: 8753302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chromogranin A: a marker of neuroendocrine tumors].
    D'Herbomez M; Gouze V
    Ann Biol Clin (Paris); 2002; 60(6):641-6. PubMed ID: 12446227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A: friend or foe of the failing myocardium?
    Schulze PC
    Eur Heart J; 2007 May; 28(9):1052-3. PubMed ID: 17456479
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological variation of plasma chromogranin A.
    Dittadi R; Meo S; Gion M; ;
    Clin Chem Lab Med; 2004 Jan; 42(1):109-10. PubMed ID: 15061392
    [No Abstract]   [Full Text] [Related]  

  • 13. Can we IMPROVE-CHF management by measuring natriuretic peptides?
    Greenberg B
    Circulation; 2007 Jun; 115(24):3045-7. PubMed ID: 17576881
    [No Abstract]   [Full Text] [Related]  

  • 14. [B-type natriuretic peptide as a predictor of sudden death in chronic heart insufficiency].
    Mikkelsen KV; Haghfelt TH
    Ugeskr Laeger; 2003 Mar; 165(13):1371-2. PubMed ID: 12703288
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated serum chromogranin A in patients with hepatocellular carcinoma.
    Leone N; Pellicano R; Brunello F; Rizzetto M; Ponzetto A
    Clin Exp Med; 2002 Nov; 2(3):119-23. PubMed ID: 12447608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in heart failure: natriuretic peptide testing.
    Rehman SU; Januzzi JL
    Panminerva Med; 2008 Jun; 50(2):139-51. PubMed ID: 18607337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are multiple biomarker testing strategies ready for prime time in heart failure?
    Lee DS; Tu JV
    Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
    [No Abstract]   [Full Text] [Related]  

  • 18. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
    Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
    Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides and heart failure.
    McLachlan CS; Yu H; Mossop P
    CMAJ; 2007 Feb; 176(5):659. PubMed ID: 17325337
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inflammatory markers in heart failure].
    Ozmen N; Cebeci BS; Kardeşoğlu E
    Anadolu Kardiyol Derg; 2006 Mar; 6(1):51-4. PubMed ID: 16524802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.